| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/16/2013 | EP2544721A1 Non-aqueous high concentration reduced viscosity suspension formulations |
| 01/16/2013 | EP2544694A2 A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 01/16/2013 | EP2544680A2 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 01/16/2013 | CN1954073B Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 01/16/2013 | CN1723039B Use for nerve growth factor antagonist in preparing medicine for treating post-surgical pain |
| 01/16/2013 | CN102884190A HJURP peptides and vaccines including the same |
| 01/16/2013 | CN102884085A Anti-ERBB3 antibodies |
| 01/16/2013 | CN102884084A 抗her2抗体及组合物 Anti-her2 antibody and compositions |
| 01/16/2013 | CN102884083A Nist DR5 binding polypeptides |
| 01/16/2013 | CN102884082A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/16/2013 | CN102884081A Methods of treating autoimmune diseases with DLL4 antagonists |
| 01/16/2013 | CN102884080A Immunoglobulin aggregate removal |
| 01/16/2013 | CN102884079A Compositions and methods for treating hepatitis virus infection |
| 01/16/2013 | CN102884078A Expression of monoclonal antibodies in ciliate host cells |
| 01/16/2013 | CN102883747A Novel antibody to a carbonic anhydrase |
| 01/16/2013 | CN102876637A Anti-GLIPR-2 monoclonal antibody hybridoma cell and anti-GLIPR-2 monoclonal antibody generated from same |
| 01/16/2013 | CN102876636A Monoclonal antibody of hemophilus parasuis resistant OMP5 (outer membrane protein), hybridoma cell strain HPS1E2 and application |
| 01/16/2013 | CN102876635A Haemophilus parasuis outer membrane protein P5 (OMP5) resistant monoclonal antibody, hybridoma cell strain and application |
| 01/16/2013 | CN102876634A PMSG (pregnant mare serum gonadotropin) double-antibody sandwich ELISA (enzyme-linked immunosorbent assay) kit |
| 01/16/2013 | CN102875682A Quail immunoglobulin G (IgG) resistant monoclonal antibody and application of monoclonal antibody in preparing antibody detection reagent kit for quail serums |
| 01/16/2013 | CN102875681A Anti-alpha v beta 6 antibodies and uses thereof |
| 01/16/2013 | CN102875680A Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 01/16/2013 | CN102875679A Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/16/2013 | CN102875678A Human anti-human CD20 monoclonal antibody molecule and application thereof |
| 01/16/2013 | CN102875677A Humanized anti-egfl7 antibodies and methods using same |
| 01/16/2013 | CN102875676A Human anti-human VEGF monoclonal antibody molecule and application thereof |
| 01/16/2013 | CN102875675A Anti-human serum albumin single-chain antibody and method for connecting polypeptide medicine with nitrogen terminal of antibody |
| 01/16/2013 | CN102875674A Anti-tetanotoxin antibody, and preparation method and application thereof |
| 01/16/2013 | CN102875673A Preparation method of egg yolk antibody for treating multocida pasteurellosis |
| 01/16/2013 | CN102875672A Preparation method of egg yolk antibody for preventing and curing duck virus hepatitis A variant strain |
| 01/16/2013 | CN102875671A Clothianidin antigen, antibody and application thereof |
| 01/16/2013 | CN102875670A Mouse ascites inducer and application thereof |
| 01/16/2013 | CN102212136B ScFv (single chain variable fragment) antibody used for detecting norfloxacin, and encoding gene and application thereof |
| 01/16/2013 | CN102212133B Fab segment of human-source human immunodeficiency virus (HIV) antibody and coded gene and application thereof |
| 01/16/2013 | CN102154218B Hybridoma cell strain 4e9 and monoclonal antibody produced by using hybridoma cell strain 4e9 |
| 01/16/2013 | CN101928346B Monoclonal antibody of anti-human tissue kallikrein and preparation method thereof |
| 01/16/2013 | CN101901656B Preparation method of magnetic particle with surface modified isothiocyanato active group |
| 01/16/2013 | CN101805405B Anti-MFAP3L monoclonal antibody and use thereof in tumor detection |
| 01/16/2013 | CN101704889B Method for preparing chicken bursal antibody |
| 01/16/2013 | CN101411876B Neurotoxic oligomers |
| 01/16/2013 | CN101294164B Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody |
| 01/16/2013 | CN101095053B Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 01/15/2013 | US8354513 Polynucleotides encoding BSL2vcvc-lg |
| 01/15/2013 | US8354510 Mutant protein |
| 01/15/2013 | US8354509 Antibodies to human programmed death receptor PD-1 |
| 01/15/2013 | US8354508 PRO115 antibody compositions and methods of use |
| 01/15/2013 | US8354507 humanized monoclonal antibodies; complementarity determining region of murine monoclonal antibody heavy chain variable domain operably fused to human heavy chain framework domain; induce apoptosis in HLA-DR-expressing tumor cells |
| 01/15/2013 | US8354506 Antibodies for the selective determination of procalcitonin 1-116 |
| 01/15/2013 | US8354372 Cyclised alpha-conotoxin peptides |
| 01/15/2013 | US8354276 T-cell compositions that elicit type I cytokine response |
| 01/15/2013 | US8354247 Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
| 01/15/2013 | US8354108 Fully human antibody to human TNFα, molecular evolution and use thereof |
| 01/15/2013 | US8354107 Method of treating amykloidosis comprising administering an anti-HMGB-1 antibody |
| 01/15/2013 | US8354105 Methods for modulating mannose content of recombinant proteins |
| 01/15/2013 | US8354103 Human antibodies to human angiopoietin-like protein 4 |
| 01/15/2013 | US8354102 Antibodies directed to mGluR7 |
| 01/15/2013 | US8354066 Artificial receptors |
| 01/15/2013 | CA2475929C Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/15/2013 | CA2466156C Ehrlichia disulfide bond formation proteins and uses thereof |
| 01/15/2013 | CA2443323C Nucleic acid vaccines for prevention of flavivirus infection |
| 01/15/2013 | CA2400842C Novel compounds |
| 01/10/2013 | WO2013006505A1 Use of anti-cd83 agonist antibodies for treating autoimmune diseases |
| 01/10/2013 | WO2013006490A2 Antibodies that specifically bind to tim3 |
| 01/10/2013 | WO2013006479A2 Mammalian cell culture |
| 01/10/2013 | WO2013006474A2 Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders |
| 01/10/2013 | WO2013006454A1 Arginine - free tnfr : fc- fusion polypeptide compositions and methods of use |
| 01/10/2013 | WO2013006437A1 Method for treating metabolic disorders |
| 01/10/2013 | WO2013005873A1 An antibody inducing antigen-specific t cell tolerance and use thereof |
| 01/10/2013 | WO2013005839A1 Phosphorylated peptide, hard tissue and/or ectopic calcification inhibitor, antibody, and hard tissue and/or ectopic calcification promoter |
| 01/10/2013 | WO2013005649A1 Anti-human ccr6 antibody |
| 01/10/2013 | WO2013005194A2 Multispecific antibodies |
| 01/10/2013 | WO2013004841A1 Modulation of complement-dependent cytotoxicity through modifications of the c-terminus of antibody heavy chains |
| 01/10/2013 | WO2013004806A1 Therapeutic combinations of anti -cd20 and anti - gm - csf antibodies and uses thereof |
| 01/10/2013 | WO2013004717A1 Biochemical markers for neurodegenerative conditions |
| 01/10/2013 | WO2013004185A1 Broadly cross-reactive hiv-1-specific antibodies for prevention and treatment of hiv |
| 01/10/2013 | WO2013004076A1 Agr2 blocking antibody and use thereof |
| 01/10/2013 | WO2013004020A1 Pseudomonas aeruginosa (pa-msha) strain igy and preparation method and use thereof |
| 01/10/2013 | WO2012158818A3 Multi-specific fab fusion proteins and methods of use |
| 01/10/2013 | WO2012141554A3 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
| 01/10/2013 | WO2012138102A3 Dlk1-specific human antibodies and pharmaceutical composition containing same |
| 01/10/2013 | WO2012138100A3 Activin receptor type ii b inhibitors comprising dlk1 extracellular water-soluble domain |
| 01/10/2013 | WO2012097313A3 Therapeutic antibodies against ror-1 protein and methods for use of same |
| 01/10/2013 | US20130012441 Prediction and prevention of preeclampsia |
| 01/10/2013 | US20130011900 Nucleophilic catalysts for oxime linkage |
| 01/10/2013 | US20130011869 Novel monoclonal antibodies and method of immunological analysis of d-dimer |
| 01/10/2013 | US20130011865 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 01/10/2013 | US20130011863 Follistatin-Like Protein-1 as a Biomarker for Sepsis |
| 01/10/2013 | US20130011861 Modulators of p-selectin glycoprotein ligand 1 |
| 01/10/2013 | US20130011858 Methods for predicting pregnancy outcome in a subject by hcg assay |
| 01/10/2013 | US20130011847 Estrogen receptors and methods of use |
| 01/10/2013 | US20130011497 Method of treatment and screening method |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011418 Antibody-Drug Conjugates |
| 01/10/2013 | US20130011415 Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof |
| 01/10/2013 | US20130011414 Broadly cross-reactive hiv-1-specific antibodies for prevention and treatment of hiv |
| 01/10/2013 | US20130011413 Method and Pharmaceutical Composition for Treatment of Intestinal Disease |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011406 Anti-kit antibodies and uses thereof |
| 01/10/2013 | US20130011404 Methods and Compositions for Regulating Musashi Function |